BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28217867)

  • 1. Effects of 25-hydroxyvitamin D and vitamin D-binding protein on bone mineral density and disease activity in Malaysian patients with rheumatoid arthritis.
    Wong TH; Gupta ED; Radhakrishnan AK; Gun SC; Chembalingam G; Yeap SS
    Int J Rheum Dis; 2018 May; 21(5):992-1000. PubMed ID: 28217867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calculation of free and bioavailable vitamin D and its association with bone mineral density in Malaysian women.
    Thambiah SC; Wong TH; Gupta ED; Radhakrishnan AK; Gun SC; Chembalingam G; Lai LC; Yeap SS
    Malays J Pathol; 2018 Dec; 40(3):287-294. PubMed ID: 30580359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlational analysis of bone health status and vitamin D-related biomarkers in women working in agriculture.
    Cho MC; Park KS; Shin JK; Lee SA; Cho IA; Jo HC; Kim SC; Choi WJ
    Medicine (Baltimore); 2021 Aug; 100(34):e27071. PubMed ID: 34449504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D deficiency and low bone mineral density in native Chinese rheumatoid arthritis patients.
    Chen J; Liu W; Lin Q; Chen L; Yin J; Huang H
    Int J Rheum Dis; 2014 Jan; 17(1):66-70. PubMed ID: 24131858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between serum 25-hydroxyvitamin D and disease activity, inflammatory cytokines and bone loss in patients with rheumatoid arthritis.
    Hong Q; Xu J; Xu S; Lian L; Zhang M; Ding C
    Rheumatology (Oxford); 2014 Nov; 53(11):1994-2001. PubMed ID: 24907153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Profile and Bone Status in Post-Menopausal Women with Rheumatoid Arthritis: A Monocentric Retrospective Survey.
    Paolino S; Hysa E; Stoian SA; Gotelli E; Casabella A; Clini PV; Pacini G; Pizzorni C; Sulli A; Nikiphorou E; Smith V; Cutolo M
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579044
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of vitamin D on disease activity and serum interleukin-6 in rheumatoid arthritis.
    Gopal K; Thevarajah M; Ng CM; Raja J
    Int J Rheum Dis; 2019 May; 22(5):834-841. PubMed ID: 30729713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome.
    Aggarwal A; Yadav AK; Ramachandran R; Kumar V; Kumar V; Sachdeva N; Khandelwal N; Jha V
    Nephrology (Carlton); 2016 Jun; 21(6):483-9. PubMed ID: 26428957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D levels and bone mass in rheumatoid arthritis.
    Brance ML; Brun LR; Lioi S; Sánchez A; Abdala M; Oliveri B
    Rheumatol Int; 2015 Mar; 35(3):499-505. PubMed ID: 24980067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of 25-hydroxyvitamin D with areal and volumetric measures of bone mineral density and parathyroid hormone: impact of vitamin D-binding protein and its assays.
    Jemielita TO; Leonard MB; Baker J; Sayed S; Zemel BS; Shults J; Herskovitz R; Denburg MR
    Osteoporos Int; 2016 Feb; 27(2):617-26. PubMed ID: 26359185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive Correlations Between Free Vitamin D and Bone Variables in a Group of Young Lebanese Women.
    Alwan A; Rizkallah M; Maalouf G; Matta J; Frenn F; Barakat A; Bachour F; Sebaaly A; Berro AJ; Al Rassy N; Howayek M; Zouhal H; El Hage R
    J Clin Densitom; 2018; 21(3):446-452. PubMed ID: 29678393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship.
    Powe CE; Ricciardi C; Berg AH; Erdenesanaa D; Collerone G; Ankers E; Wenger J; Karumanchi SA; Thadhani R; Bhan I
    J Bone Miner Res; 2011 Jul; 26(7):1609-16. PubMed ID: 21416506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe.
    Cutolo M; Otsa K; Laas K; Yprus M; Lehtme R; Secchi ME; Sulli A; Paolino S; Seriolo B
    Clin Exp Rheumatol; 2006; 24(6):702-4. PubMed ID: 17207389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Vitamin D Deficiency in Black Americans: Comparison of Total, Free, Bioavailable 25 Hydroxy Vitamin D Levels with Parathyroid Hormone Levels and Bone Mineral Density.
    McKee A; Lima Ribeiro SM; Malmstrom TK; Perry HM; Miller DK; Farr SS; Niehoff ML; Albert SG
    J Nutr Health Aging; 2018; 22(9):1045-1050. PubMed ID: 30379301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between endothelial dysfunction and osteoprotegerin, vitamin D, and bone mineral density in patients with rheumatoid arthritis.
    Delgado-Frías E; López-Mejias R; Genre F; Ubilla B; Gómez Rodríguez-Bethencourt MA; González-Díaz A; de Vera-González AM; González-Rivero AF; Díaz-González F; González-Gay MA; Ferraz-Amaro I
    Clin Exp Rheumatol; 2015; 33(2):241-9. PubMed ID: 25797915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why don't serum vitamin D concentrations associate with BMD by DXA? A case of being 'bound' to the wrong assay? Implications for vitamin D screening.
    Allison RJ; Farooq A; Cherif A; Hamilton B; Close GL; Wilson MG
    Br J Sports Med; 2018 Apr; 52(8):522-526. PubMed ID: 28798036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble receptor activator of NFkappa B-ligand and osteoprotegerin in rheumatoid arthritis - relationship with bone mineral density, disease activity and bone turnover.
    Oelzner P; Franke S; Lehmann G; Eidner T; Müller A; Wolf G; Hein G
    Clin Rheumatol; 2007 Dec; 26(12):2127-2135. PubMed ID: 17541498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone health.
    Walsh JS; Evans AL; Bowles S; Naylor KE; Jones KS; Schoenmakers I; Jacques RM; Eastell R
    Am J Clin Nutr; 2016 Jun; 103(6):1465-71. PubMed ID: 27169839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower concentration of vitamin D is associated with lower DAS28 and VAS-pain scores in patients with inflammatory rheumatic diseases treated with infliximab: a pilot study.
    Miler M; Nikolac Gabaj N; Grazio S; Vahtarić A; Vrtarić A; Grubišić F; Skala Kavanagh H; Doko Vajdić I; Vrkić N
    Rheumatol Int; 2020 Sep; 40(9):1455-1461. PubMed ID: 32462255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density, vitamin D receptor (VDR) gene polymorphisms, fracture risk assessment (FRAX), and trabecular bone score (TBS) in rheumatoid arthritis patients: connecting pieces of the puzzle.
    Senosi MR; Fathi HM; Baki NMA; Zaki O; Magdy AM; Gheita TA
    Clin Rheumatol; 2022 May; 41(5):1333-1342. PubMed ID: 35048212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.